Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-109.86%Return on Equity
VS
Market
Sector
Industry
History
$ 3.7Close
$ 0.88 - $ 4.74 52-Week Range
Ticker Information
Ticker
PYXSCompany Name
PYXIS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPYXIS ONCOLOGY INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PYXS - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 87.64M | $ -96.29M | -109.86% |
| 3/31/2025 | $ 103.1M | $ -95.23M | -92.37% |
| 12/31/2024 | $ 120.75M | $ -77.33M | -64.04% |
| 9/30/2024 | $ 153.68M | $ -57.36M | -37.32% |
| 6/30/2024 | $ 169.79M | $ -59.2M | -34.87% |
| 3/31/2024 | $ 184.16M | $ -57.8M | -31.39% |
| 12/31/2023 | $ 125.7M | $ -73.79M | -58.7% |
| 9/30/2023 | $ 137.95M | $ -94.29M | -68.36% |
| 6/30/2023 | $ 145.28M | $ -98.92M | -68.09% |
| 3/31/2023 | $ 152.16M | $ -108.58M | -71.36% |
Key Performance Insights, Last 5 Years
- PYXIS ONCOLOGY INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, PYXIS ONCOLOGY INC's average ROE has been -59.69%.
- The median ROE for PYXIS ONCOLOGY INC during this period was -61.37%
- PYXIS ONCOLOGY INC reached its highest ROE over the past 5 years at -29.07%.
- The lowest ROE recorded by PYXIS ONCOLOGY INC in the same timeframe -109.86%
PYXIS ONCOLOGY INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for PYXIS ONCOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -12.83M ] / Equity [ $ -15.64M ]
(=) ROE [ 0% ] PYXS - Return on Equity, Last 5 years
-109.86%
Minimum
Jun 30, 2025
-29.07%
Maximum
Dec 31, 2021
-59.69%
Average
-61.37%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |